Genetic Diseases of the Nervous System

  • Thomas D. Bird
  • S. Mark Sumi

Abstract

All human diseases, including those of the nervous system, are the result of interactions between genetic factors and the environment. In some diseases the genetic factors are relatively minor and of little importance. Other disorders are strictly inherited conditions, and genetic factors are paramount. The major categories of genetic influence are single gene (mendelian), gross chromosomal aberration, mitochondrial, and multifactorial/polygenic. Examples of neurologic diseases representing each of these caregories are illustrated in this chapter.

Keywords

Duchenne Muscular Dystrophy Spinal Muscular Atrophy Tuberous Sclerosis Duchenne Muscular Dystrophy Myotonic Dystrophy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lampe T, Bird TD, Nochlin D, et al.: Phenotype of chromosome 14-linked familial Alzheimer’s disease in a large kindred. Ann Neurol 1994, 36:368–378.PubMedCrossRefGoogle Scholar
  2. 2.
    Van Broeckhoven CL: Molecular genetics of Alzheimer disease: identification of genes and gene mutations. Eur Neurol 1995, 35: 8–19.PubMedCrossRefGoogle Scholar
  3. 3.
    Sherrington R, Rogaev EI, Liang Y, et al.: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature 1995, 375:754–760.PubMedCrossRefGoogle Scholar
  4. 4.
    Levy-Lahad E, Wasco W, Poorkaj P, et al.: Candidate gene for the chromosome 1 familial Alzheimer’s disease locus. Science 1995, 269:973–977.Google Scholar
  5. 5.
    Roses AD: Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer’s disease. Ann Neurol 1995, 18: 6–14.CrossRefGoogle Scholar
  6. 6.
    Levy-Lahad E, Bird TD: Alzheimer’s Disease: Genetic Factors. In Neurogenetics. Edited by Pulst SM. New York: Oxford University Press, 1999: 317–333.Google Scholar
  7. 7.
    Rosenberg RN: The molecular and genetic basis of AD: the end of the beginning: the 2000 Wartenberg lecture. Neurology 2000, 54: 2045–2054.PubMedCrossRefGoogle Scholar
  8. 8.
    Nochlin D, Sumi SM, Bird TD, et al.: Familial dementia with PrP-positive amyloid plaques: a variant of Gerstmann-Straussler syndrome. Neurol 1989, 39:910–918.Google Scholar
  9. 9.
    Mastrianni JA: The prion diseases: Creutzfeldt-Jakob, Gerstmann-StrausslerScheinker, and related disorders. J Geriatr Psychiatry Neural 1998, 11: 78–97.Google Scholar
  10. 10.
    Wilhelmsen KC: Frontotemporal dementia genetics. J Geriatr Psychiatry Neurol 1998, 11: 55–60.PubMedGoogle Scholar
  11. 11.
    Navon R, Argov Z, Frisch A: Hexosaminidase A deficiency in adults. Am J Med Genet 1986, 24: 179–196.PubMedCrossRefGoogle Scholar
  12. 12.
    Millat G, Marcais C, Rafi M, et al.: Niemann-Pick Cl disease: the I1061T substitution is a frequent mutant allele of Western European descent and correlates with a classic juvenile phenotype. JHum Genet 1999, 65:1321–1329.Google Scholar
  13. 13.
    Rousseau F, Heitz D, Tarleton J, et al.: A multicenter study on genotype-phe- notype correlations in the fragile X syndrome, using direct diagnosis with probe StB 12.3: the first 2,253 cases. Am J Hum Genet 1994, 55:225–237.Google Scholar
  14. 14.
    Fernandez M, Bird TD: Epilepsy. The Genetic Basis of Common Diseases. Edited by King R, Rotter J, Motulsky A.. New York, Oxford University Press; 2001, in press.Google Scholar
  15. 15.
    Watkins PA, Gould SJ, Smith MA, et al.: Altered expression of ALDP in X-linked adrenoleukodystrophy. Am J Hum Genet 1995, 576:292–301.Google Scholar
  16. 16.
    Garben J, Cambi F, Shy M, et al.: The molecular pathogenesis of PelizaeusMerzbacher disease. Arch Neurol 1999, 56:1210–1214.Google Scholar
  17. 17.
    Nance MA: Huntington disease: clinical, genetic, and social aspects. J Geriatr Psychiatry Neurol 1998, 11: 61–70.PubMedGoogle Scholar
  18. 18.
    Finelli PF: Kayser-Fleischer ring: hepatolenticular degeneration (Wilson’s disease). Neurology 1995, 45: 1261–1262.PubMedCrossRefGoogle Scholar
  19. 19.
    Vieregge P: Genetic factors in the etiology of idiopathic Parkinson’s disease. J Neural Transm Dement Sect 1994, 8: 1–37.CrossRefGoogle Scholar
  20. 20.
    Payami H, Zareparsi MS: Genetic epidemiology of Parkinson’s disease. J Geriatr Psychiatry Neurol 1998, 11: 98–106.PubMedGoogle Scholar
  21. 21.
    Geschwind DH, Loginov M, Stern JM: Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease). Am J Hum Genet 1999, 65: 764–772.PubMedCrossRefGoogle Scholar
  22. 22.
    Genis D, Matilla T, Volpini V, et al.: Clinical, neuropathologic, and genetic studies of a large spinocerebellar ataxia type 1 (SCA1) kindred: (CAG) expansion and early premonitory signs and symptoms. Neurology 1995, 45:24–30.Google Scholar
  23. 23.
    Matilla T, McCall A, Subramony SH, et al.: Molecular and clinical correlations in spinocerebellar ataxia type 3 and Machado-Joseph disease. Ann Neurol 1995, 38:68–72.Google Scholar
  24. 24.
    Pulst SM, Perlman S: Hereditary Ataxias. In Neurogenetics. Edited by Pulst SM. New York: Oxford University Press, 1999: 231–263.Google Scholar
  25. 25.
    Martin JJ, Martin L, Lofgren A, et al: Classical Friedreich’s ataxia and its genotype. Eur Neurol 1999, 42: 109–115.PubMedCrossRefGoogle Scholar
  26. 26.
    Savitsky K, Bar-Shira A, Gilad S, et al.: A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995, 268:1749–1753.Google Scholar
  27. 27.
    Rosen DR, Siddique T, Patterson D, et al.: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59–62.Google Scholar
  28. 28.
    Nagashima T, Seko K, Hirose K, et al Familial bulbo-spinal muscular atrophy associated with testicular atrophy and sensory neuropathy (Kennedy-Alter-Sung syndrome): autopsy case report of two brothers. J Neurol Sci 1988, 87: 141–152.PubMedCrossRefGoogle Scholar
  29. 29.
    Lefebvre S, Burglen L, Reboullet S, et al.: Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995, 80:155–165.Google Scholar
  30. 30.
    Fink JK, Hedera P: Hereditary spastic paraplegia: genetic heterogeneity and genotype-phenotype correlation. Semin Neurol 1999, 19: 301–10.PubMedCrossRefGoogle Scholar
  31. 31.
    Nelis E, Timmerman V, De Jonghe P, et al.: Molecular genetics and biology of inherited peripheral neuropathies: a fast-moving field. Neurogenetics 1999, 2:137–148.Google Scholar
  32. 32.
    Thompson MW, McInnes RR, Willard HF, eds: The Molecular and Biochemical Basis of Genetic Disease. In Genetics in Medicine, edn 5. Philadelphia: WB Saunders; 1991: 289–293.Google Scholar
  33. 33.
    Witkowski JA: Dystrophin-related muscular dystrophies. J Child Neurol 1989, 4: 251–271.PubMedCrossRefGoogle Scholar
  34. 34.
    Arikawa E, Hoffman EP, Kaido M, et al.: The frequency of patients with dystrophin abnormalities in a limb-girdle patient population. Neurology 1991, 41:1491–1496.Google Scholar
  35. 35.
    Ptaâek L: Ion channel shake-down. Nature Genet 1994, 8: 111–112.CrossRefGoogle Scholar
  36. 36.
    Laing NG, Wilton SD, Akkari PA, et al.: A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy. Nature Genet 1995:75–79.Google Scholar
  37. 37.
    Kissel JT: Facioscapulohumeral dystrophy. Semin Neurol 1999, 19: 35–45.PubMedCrossRefGoogle Scholar
  38. 38.
    Silvestri G, Ciagaloni E, Santorelli FM, et al.: Clinical features associated with the A -> G transition at nucleotide 8344 of mtDNA (“MERRF mutation”). Neurology 1993, 43:1200–1206.Google Scholar
  39. 39.
    Santorelli FM, Shanske S, Macaya A, et al.: The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh’s syndrome. Ann Neurol 1993, 34:827–834.Google Scholar
  40. 40.
    Gutmann DH, Collins FS: Recent progress toward understanding the molecular biology of Von Recklinghausen neurofibromatosis. Ann Neurol 1992, 31: 555–561.PubMedCrossRefGoogle Scholar
  41. 41.
    Parry DM, Eldridge R, Kaiser-Kupfer MI, et al.: Neurofibromatosis 2 (NF2) clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 1994, 52:450–461.Google Scholar
  42. 42.
    Crino PB, Henske EP: New developments in the neurobiology of the tuberous sclerosis complex. Neurology 1999, 53: 1384–1390.PubMedCrossRefGoogle Scholar
  43. 43.
    Jones AC, Shyamsundar MM, Thomas MW, et al: Comprehensive mutation analysis of TSC1 and TSC2- and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet 1999, 64: 1305–1315.PubMedCrossRefGoogle Scholar
  44. 44.
    Schimschock JR, Alvord E Jr, Swanson PD: Cerebrotendinous xanthomatosis: clinical and pathological studies. Arch Neurol 1968, 18: 688–698.PubMedCrossRefGoogle Scholar
  45. 45.
    Swanson PD, Cromwell LD: Magnetic resonance imaging in cerebrotendinous xanthomatosis. Neurology 1986, 36: 124–126.PubMedCrossRefGoogle Scholar
  46. 46.
    Satya-Murti S, Navada S, Eames F: Central nervous system involvement in blue-rubber-bleb-nevus syndrome. Arch Neural 1986, 43: 1184–1186.CrossRefGoogle Scholar
  47. 47.
    Duan DR, Pause A, Burgess WH, et al.: Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 1995, 269:1402–1406.Google Scholar
  48. 48.
    Lamiell JM, Salazar FG, Hsia YE: Von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine 1989, 68: 1–29.PubMedCrossRefGoogle Scholar
  49. 49.
    Rigamonti D, Hadley MN, Drayer P, et al.: Cerebral cavernous malformations: incidence and familial occurrence. N Engl JMed 1988, 319:343–347.Google Scholar
  50. 50.
    Sahoo T, Johnson EW, Thomas JW, et al.: Mutations in the gene encoding KRIT1, a Krev-1/rapla binding protein, cause cerebral cavernous malformations (CCM1). Hum Molec Genet 1999, 12:2325–2333.Google Scholar
  51. 51.
    Chataway J, Feakes R, Coraddu F, et al.: The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. Brain 1998, 121:1869–1887.Google Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Thomas D. Bird
  • S. Mark Sumi

There are no affiliations available

Personalised recommendations